Nobue Uchida
Overview
Explore the profile of Nobue Uchida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, et al.
J Palliat Med
. 2024 Dec;
28(1):42-49.
PMID: 39729365
Utility values of responders and nonresponders are essential inputs in cost-effectiveness studies of radiation therapy for painful bone metastases but, to our knowledge, they have not been reported separately. We...
2.
Utsumi N, Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, et al.
Jpn J Clin Oncol
. 2024 Oct;
55(2):140-147.
PMID: 39479804
Objective: Single-center studies or randomized controlled trials have evaluated the impact of radiotherapy for bone metastases on quality of life (QOL). We investigated the real-world impact of radiotherapy for bone...
3.
Harada H, Shikama N, Notsu A, Shirato H, Yamada K, Uezono H, et al.
J Radiat Res
. 2024 Aug;
65(5):701-711.
PMID: 39162649
Purpose of this study is to evaluate patient characteristics, treatments and outcomes in bone metastasis radiotherapy practice. Patients for whom radiotherapy for bone metastasis was planned at 26 institutions in...
4.
Saito T, Shikama N, Takahashi T, Nakamura N, Mori T, Nakajima K, et al.
J Radiat Res
. 2024 Jun;
65(4):532-539.
PMID: 38923425
We sought to identify potential evidence-practice gaps in palliative radiotherapy using quality indicators (QIs), previously developed using a modified Delphi method. Seven QIs were used to assess the quality of...
5.
Saito T, Shikama N, Takahashi T, Harada H, Ueno S, Notsu A, et al.
Br J Radiol
. 2023 Sep;
96(1151):20230351.
PMID: 37750858
Objective: To identify factors significantly associated with quality of life (QOL) and determine if these associations are strong enough to predict certain aspects of QOL without measuring them. Methods: We...
6.
Shirato H, Harada H, Iwasaki Y, Notsu A, Yamada K, Uezono H, et al.
Adv Radiat Oncol
. 2023 Apr;
8(4):101205.
PMID: 37077179
Purpose: The aim of this study was to understand the income and employment status of patients at the start of and during follow-up after palliative radiation therapy for bone metastasis....
7.
Kawamoto T, Shikama N, Imano N, Kubota H, Kosugi T, Sekii S, et al.
Breast Cancer
. 2022 Dec;
30(2):282-292.
PMID: 36528759
Background: There is a lack of data on combined radiotherapy (RT) and cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) risk factors and toxicity. This study aimed to assess the incidence...
8.
Sakaguchi H, Tsuchiya H, Kitagawa Y, Tanino T, Yoshida K, Uchida N, et al.
Int J Mol Sci
. 2022 Jan;
23(2).
PMID: 35054896
A long noncoding RNA (lncRNA), () (), is involved in the maintenance of cancer stem cells (CSCs) in hepatocellular carcinoma (HCC). CSCs are suggested to play important roles in therapeutic...
9.
Kawamoto T, Nakamura N, Saito T, Tonari A, Wada H, Harada H, et al.
Jpn J Clin Oncol
. 2021 Feb;
51(6):950-955.
PMID: 33624768
Background: International guidelines recommend brachytherapy for patients with dysphagia from esophageal cancer, whereas brachytherapy is infrequently used to palliate dysphagia in some countries. To clarify the availability of palliative treatment...
10.
Kubota H, Nakamura N, Shikama N, Tonari A, Wada H, Harada H, et al.
J Radiat Res
. 2021 Jan;
62(2):356-363.
PMID: 33454759
Evidence regarding postoperative radiation therapy (PORT) for metastases to the long bones is lacking. Characterizing the current practice patterns and identifying factors that influence dose-fractionation schedules are essential for future...